EP2701701

METHODS AND COMPOSITIONS USING PDE4 INHIBITORS FOR THE TREATMENT AND MANAGEMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    27.4.2012
  • EP published:
    24.1.2018
  • EP application number:
    12719228.4
  • Max expiry date:
    26.4.2032
  • Title:
    METHODS AND COMPOSITIONS USING PDE4 INHIBITORS FOR THE TREATMENT AND MANAGEMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES

Timeline

Today
27.4.2012EP application
24.1.2018EP Publication

Owner

  • Name:
    Celgene Corporation
  • Address:
    86 Morris Avenue, 07901, Summit, NJ, US

Inventor

  • Name:
    SCHAFER, Peter
  • Address:
    SomersetNJ, US
  • Name:
    GANDHI, Anita
  • Address:
    BernardsvilleNJ, US
  • Name:
    CAPONE, Lori
  • Address:
    EdisonNJ, US

Priority

  • Number:
    201161480263 P
  • Date:
    28.4.2011
  • Country:
    US

Classification

  • Categories:
    A61K 31/4035, A61K 38/13, A61K 45/06, A61K 38/17, A61K 39/395, A61K 31/10, A61K 31/165, A61K 31/40, A61K 31/4015, A61K 31/519

Upload documents